BIORESTORATIVE THERAPIES, INC. (BRTX) Quick Ratio
- Quick ratio · latest quarter: Value 2.23×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31..
Quick ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 2.23× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31. $3.61M ÷ $1.61M ≈ 2.23× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 3.61M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.61M USD | Liabilities, Current |
| Cash and equivalents | 3.11M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 479.35K USD | Marketable Securities, Current |
| Customer receivables | 13.30K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.61M | $1.61M | $3.11M | $479.35K | $13.30K | (m) | 2.23× |
| 2025-12-31 | $2.97M | $3.72M | $1.51M | $1.44M | $15.50K | (m) | 0.80× |
| 2025-09-30 | $4.50M | $3.44M | $602.44K | $3.89M | $13.40K | (m) | 1.31× |
| 2025-06-30 | $7.40M | $3.67M | $1.56M | $5.83M | $15.00K | (m) | 2.01× |
| 2025-03-31 | $9.14M | $4.18M | $1.23M | $7.88M | $25.00K | (m) | 2.19× |
| 2024-12-31 | $10.92M | $3.75M | $547.89K | $10.18M | $188.40K | (m) | 2.91× |
| 2024-09-30 | $13.25M | $4.58M | $1.49M | $11.60M | $165.00K | (m) | 2.89× |
| 2024-06-30 | $14.71M | $5.32M | $2.25M | $12.43M | $27.40K | (m) | 2.76× |
| 2024-03-31 | $16.45M | $3.45M | $1.16M | $15.26M | $35.00K | (m) | 4.77× |
| 2023-12-31 | $11.09M | $1.06M | $884.38K | $10.18M | $19.30K | (m) | 10.42× |
| 2023-09-30 | $12.28M | $932.62K | $2.44M | $9.80M | $39.30K | (m) | 13.17× |
| 2023-06-30 | $11.64M | $812.85K | $1.78M | $9.83M | $25.00K | (m) | 14.32× |
| 2023-03-31 | $12.39M | $470.39K | $1.84M | $10.54M | $16.00K | (m) | 26.34× |
| 2022-12-31 | $14.77M | $440.30K | $1.68M | $13.07M | $16.00K | (m) | 33.53× |
| 2022-09-30 | $16.53M | $717.18K | $6.57M | $9.91M | $45.00K | (m) | 23.05× |
| 2022-06-30 | (m) | $621.78K | (m) | (m) | $16.00K | (m) | (m) |
| 2022-03-31 | (m) | $493.83K | (m) | (m) | $16.00K | (m) | (m) |
| 2021-12-31 | (m) | $363.82K | (m) | (m) | $5.00K | (m) | (m) |
| 2021-09-30 | (m) | $873.47K | (m) | (m) | $8.00K | (m) | (m) |
| 2021-06-30 | (m) | $1.33M | (m) | (m) | $15.00K | (m) | (m) |
| 2021-03-31 | (m) | $1.29M | (m) | (m) | $18.00K | (m) | (m) |
| 2020-12-31 | (m) | $1.04M | (m) | (m) | $17.00K | (m) | (m) |
| 2020-09-30 | (m) | $1.37M | (m) | (m) | $15.00K | (m) | (m) |
| 2020-06-30 | (m) | $881.53K | (m) | (m) | $19.00K | (m) | (m) |
| 2020-03-31 | (m) | $18.42M | (m) | (m) | $26.00K | (m) | (m) |
| 2019-12-31 | (m) | $13.72M | (m) | (m) | $32.00K | (m) | (m) |
| 2019-09-30 | (m) | $13.72M | (m) | (m) | $38.00K | (m) | (m) |
| 2019-06-30 | (m) | $11.14M | (m) | (m) | $31.00K | (m) | (m) |
| 2019-03-31 | (m) | $8.73M | (m) | (m) | $29.00K | (m) | (m) |
| 2018-12-31 | (m) | $9.25M | (m) | (m) | $29.00K | (m) | (m) |
| 2018-09-30 | (m) | $8.92M | (m) | (m) | $26.00K | (m) | (m) |
| 2018-06-30 | (m) | $10.69M | (m) | (m) | $37.00K | (m) | (m) |
| 2018-03-31 | (m) | $8.82M | (m) | (m) | $19.00K | (m) | (m) |
| 2017-12-31 | (m) | $8.35M | (m) | (m) | $38.00K | (m) | (m) |
| 2017-09-30 | (m) | $8.04M | (m) | (m) | $16.00K | (m) | (m) |
| 2017-06-30 | (m) | $6.99M | (m) | (m) | $20.00K | (m) | (m) |
| 2017-03-31 | (m) | $6.06M | (m) | (m) | $7.00K | (m) | (m) |
| 2016-12-31 | (m) | $5.84M | (m) | (m) | $6.00K | (m) | (m) |
| 2016-09-30 | (m) | $5.55M | (m) | (m) | $5.00K | (m) | (m) |
| 2016-06-30 | (m) | $5.70M | (m) | (m) | $16.00K | (m) | (m) |
| 2016-03-31 | (m) | $5.59M | (m) | (m) | $9.00K | (m) | (m) |
| 2015-12-31 | (m) | $5.61M | (m) | (m) | $93.38K | (m) | (m) |
| 2015-09-30 | (m) | $5.47M | (m) | (m) | (m) | $2.49K | (m) |
| 2015-06-30 | (m) | $4.92M | (m) | (m) | $50.98K | $2.49K | (m) |
| 2015-03-31 | (m) | $8.92M | (m) | (m) | (m) | $1.93K | (m) |
| 2014-12-31 | (m) | $8.52M | (m) | (m) | (m) | $1.95K | (m) |
| 2014-09-30 | (m) | $7.43M | (m) | (m) | (m) | $17.39K | (m) |
| 2014-06-30 | (m) | $8.26M | (m) | (m) | (m) | $17.79K | (m) |
| 2014-03-31 | (m) | $7.93M | (m) | (m) | (m) | $17.90K | (m) |
| 2013-12-31 | (m) | $7.50M | (m) | (m) | (m) | $17.96K | (m) |
| 2013-09-30 | (m) | $7.86M | (m) | (m) | (m) | $17.96K | (m) |
| 2013-06-30 | (m) | $3.35M | (m) | (m) | (m) | $13.79K | (m) |
| 2013-03-31 | (m) | $3.06M | (m) | (m) | (m) | $13.82K | (m) |
| 2012-12-31 | (m) | $2.82M | (m) | (m) | (m) | $12.48K | (m) |
| 2012-09-30 | (m) | $6.48M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $5.60M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $4.41M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $3.91M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $3.75M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $2.81M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.02M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |